Regeneron Pharmaceuticals has signed an agreement with the U.S.
Regeneron Pharmaceuticals, Inc (REGN) announced on Tuesday that it has won a $450 million contract with the U.S government to manufacture and supply …
Regeneron Pharmaceuticals, Inc (REGN) said Thursday it started the first human clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention …
U.S.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) have excited investors with key clinical moves forward for the firms, between VRTX’s double …
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (NYSE:SNY) announced that the FDA approved DUPIXENT® (dupilumab) Injection, the first and only biologic medicine approved for …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi announced that they will appeal the injunction granted today by the U.S.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that Jay Markowitz, M.D.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Geisinger Health System (Geisinger) today announced that Science has published a paper describing how the DiscovEHR collaboration between …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for …
